en
Feedback
Marrow Notes

Marrow Notes

Open in Telegram

📈 Analytical overview of Telegram channel Marrow Notes

Channel Marrow Notes (@marrow_edition9notes) in the English language segment is an active participant. Currently, the community unites 125 242 subscribers, ranking 80 in the Medicine category and 1 938 in the India region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 125 242 subscribers.

According to the latest data from 11 June, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -206 over the last 30 days and by -3 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 15.45%. Within the first 24 hours after publication, content typically collects N/A% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 0 views. Within the first day, a publication typically gains 0 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 0.

📝 Description and content policy

Channel description not provided.

Thanks to the high frequency of updates (latest data received on 12 June, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.

125 242
Subscribers
-324 hours
-707 days
-20630 days

Data loading in progress...

Similar Channels
No data
Any problems? Please refresh the page or contact our support manager.
Tags Cloud
No data
Any problems? Please refresh the page or contact our support manager.
Incoming and Outgoing Mentions
---
---
---
---
---
---
Attracting Subscribers
June '26
June '26
+61
in 0 channels
May '26
+308
in 0 channels
Get PRO
April '26
+471
in 2 channels
Get PRO
March '26
+411
in 0 channels
Get PRO
February '26
+1 205
in 0 channels
Get PRO
January '26
+1 453
in 0 channels
Get PRO
December '25
+1 214
in 1 channels
Get PRO
November '25
+1 003
in 0 channels
Get PRO
October '250
in 0 channels
Get PRO
September '250
in 0 channels
Get PRO
August '250
in 0 channels
Get PRO
July '250
in 0 channels
Get PRO
June '250
in 0 channels
Get PRO
May '250
in 0 channels
Get PRO
April '25
+1
in 0 channels
Get PRO
March '25
+1
in 0 channels
Get PRO
February '250
in 0 channels
Get PRO
January '250
in 0 channels
Get PRO
December '240
in 0 channels
Get PRO
November '240
in 0 channels
Get PRO
October '240
in 0 channels
Get PRO
September '24
+1 477
in 0 channels
Get PRO
August '24
+1 441
in 0 channels
Get PRO
July '24
+1 735
in 0 channels
Get PRO
June '24
+1 849
in 0 channels
Get PRO
May '24
+3 870
in 0 channels
Get PRO
April '240
in 0 channels
Get PRO
March '24
+2 024
in 0 channels
Get PRO
February '24
+1 241
in 0 channels
Get PRO
January '24
+1 364
in 0 channels
Get PRO
December '23
+13 105
in 0 channels
Get PRO
November '230
in 0 channels
Get PRO
October '230
in 0 channels
Get PRO
September '230
in 0 channels
Get PRO
August '230
in 0 channels
Get PRO
July '230
in 0 channels
Get PRO
June '230
in 0 channels
Get PRO
May '230
in 0 channels
Get PRO
April '230
in 0 channels
Get PRO
March '23
+3 881
in 0 channels
Get PRO
February '230
in 0 channels
Get PRO
January '230
in 0 channels
Get PRO
December '22
+1 482
in 0 channels
Get PRO
November '22
+1 805
in 0 channels
Get PRO
October '22
+1 736
in 0 channels
Get PRO
September '22
+3 416
in 0 channels
Get PRO
August '22
+4 091
in 0 channels
Get PRO
July '22
+8 254
in 0 channels
Get PRO
June '22
+8 833
in 0 channels
Get PRO
May '22
+7 177
in 0 channels
Get PRO
April '22
+7 855
in 0 channels
Get PRO
March '22
+9 952
in 0 channels
Get PRO
February '22
+6 594
in 0 channels
Get PRO
January '22
+3 680
in 0 channels
Get PRO
December '21
+66
in 0 channels
Get PRO
November '21
+4 539
in 0 channels
Get PRO
October '21
+5 844
in 0 channels
Get PRO
September '21
+5 426
in 0 channels
Get PRO
August '21
+5 610
in 0 channels
Get PRO
July '21
+8 481
in 0 channels
Get PRO
June '21
+4 907
in 0 channels
Get PRO
May '21
+5 065
in 0 channels
Get PRO
April '21
+3 697
in 0 channels
Get PRO
March '21
+2 630
in 0 channels
Get PRO
February '21
+2 268
in 0 channels
Date
Subscriber Growth
Mentions
Channels
12 June0
11 June+13
10 June+10
09 June+22
08 June0
07 June0
06 June+5
05 June0
04 June+1
03 June+3
02 June+7
01 June0
Channel Posts
Malignant testicular neoplasms Type Features Germ cell (95%)Seminoma• Retain features of spermatogenesis • β-hCG, AFP usually negative Nonseminoma• ≥1 partially differentiated cells: yolk sac, embryonal carcinoma, teratoma, and/or choriocarcinoma • β-hCG, AFP usually positive Stromal (5%)Leydig• Often produces excessive estrogen (gynecomastia) or testosterone (acne) • Can cause precocious puberty Sertoli• Rare • Occasionally associated with excessive estrogen secretion (eg, gynecomastia) AFP = alpha-fetoprotein. This patient with a testicular mass, gynecomastia, and elevated estrogen levels likely has a Leydig cell tumor, the most common type of testicular sex cord stromal tumor. These tumors arise from supporting cells of the testis such as Leydig, Sertoli, and granulosa cells; they account for approximately 5% of testicular tumors (germ cell tumors account for ~95%), arise in a wide range of ages, and have no clearly defined risk factors. Leydig cells are the primary source of testicular testosterone but are also capable of generating estrogen. Therefore, Leydig cell tumors often present with endocrine manifestations due to excessive estrogen (eg, gynecomastia, loss of libido, erectile dysfunction) or testosterone (eg, acne, hirsutism). Examination frequently reveals a testicular mass, which is typically confirmed by bilateral scrotal ultrasound. In contrast to many germ cell tumors, Leydig cells do not generally produce serum tumor markers such as β-hCG or alpha-fetoprotein (AFP). However, the generation of estrogen or testosterone often leads to FSH and LH suppression. (Choices A, D, and E) Choriocarcinoma, teratoma, and yolk sac tumors are nonseminomatous germ cell tumors. They typically present with a painless, firm testicular mass. However, they often produce β-hCG (particularly choriocarcinoma) or AFP (particularly yolk sac tumors) in addition; estrogen production is rare, so feminization is uncommon. (Choice C) Seminoma is a germ cell tumor that does not usually produce β-hCG, AFP, or estrogen. Therefore, feminization would be atypical. Most seminomas present with a painless, unilateral testicular mass or swelling. TAKE HOME MESSAGE Leydig cell testicular tumors often cause feminization (eg, gynecomastia) due to the production of estrogen by tumor cells. This frequently causes secondary inhibition of FSH and LH. Serum tumor markers (eg, β-hCG, AFP) are not usually elevated.

2
Which of the following is the most likely diagnosis in this patient? #NEETPG #INICET
30 001
3
A 35-year-old man comes to the office due to a progressive increase in breast size over the past 6 months. He is sexually active, has no chronic medical conditions, and takes no medications. The patient does not use tobacco, alcohol, or illicit drugs. Vital signs are normal. BMI is 28 kg/m². Gynecomastia with mild bilateral breast tenderness is present. Genitourinary examination reveals a 1-cm nodule in the right testis. The examination is otherwise normal. Laboratory results are as follows: LH: 3 U/L (normal: 6–23 U/L) FSH: 2 U/L (normal: 4–25 U/L) Testosterone: 270 ng/dL (normal: 300–1,000 ng/dL) Estradiol: 115 pg/mL (normal: 20–60 pg/mL) β-hCG: undetectable Alpha-fetoprotein: undetectable
28 384
4
Join PROFWISE MBBS Groups! 1. 1st PROF MBBS: https://t.me/+rMA2Sew_gp41MDk1 2. 2nd PROF MBBS: https://t.me/+SD0oh2UMHAFmNjM1 3. 3rd PROF MBBS: https://t.me/+yxj_Ruzm37o0MDY1 4. FINAL PROF MBBS: https://t.me/+WQnwlzhiBU1hMTc1 5. FMGE (Abroad MBBS): https://t.me/FMGEgroupstudents 6. NEET PG/INICET (Interns/Post-interns): https://t.me/+TfvNbL3UWlw1NWI1 7. NEET SS/INI SS (Residents): https://t.me/Neet_SS Join respective group only! ⚠️ Queries: https://t.me/murtazakuchay (@murtazakuchay) 💬
1
5
FEW HOURS LEFT FOR HOURS 📅 *Version XI ELITE Plan* is still available at Flat 40% OFF 📉 — buy by today 11;59 pm this price
FEW HOURS LEFT FOR HOURS 📅 *Version XI ELITE Plan* is still available at Flat 40% OFF 📉 — buy by today 11;59 pm this price is history. *Register for Discount* 👉: https://prepladder.com/app/resolve-live-classes-381--DCTRXNSQ Till Neet PG Plan- *₹7899* 💰 12 months *17499* 🗓️ 16 months *21499* 24 months *25499* 36 months *30999* 48 months *34999* ☮️ Use Best Code: *DCTRXNSQ* 🎟️ *Register Offer Link* : https://prepladder.com/app/resolve-live-classes-381--DCTRXNSQ Max Discount: DCTRXNSQ 🏷️ Join group offer https://chat.whatsapp.com/FdIInMlLAOeFl2kvg2xhT8?mode=gi_t
2 922
6
Tomorrow is where hesitation gets expensive. 😵‍💫⏳ *Version XI ELITE Plan is still available at Flat 40% OFF* — but by tomor
Tomorrow is where hesitation gets expensive. 😵‍💫⏳ *Version XI ELITE Plan is still available at Flat 40% OFF* — but by tomorrow, this price is history. *Register for Discount* 👉: https://prepladder.com/app/resolve-live-classes-381--DCTRXNSQ Till Neet PG Plan- *₹7899* 12 months *17499* 16 months *21499* 24 months *25499* 36 months *30999* 48 months *34999* ☮️ Use Best Code: *DCTRXNSQ* *Register Offer Link* : https://prepladder.com/app/resolve-live-classes-381--DCTRXNSQ Max Discount: *DCTRXNSQ* *Dm Quick and get check that you avail all the possible discount.*
6 234